Drug Reference
Vorapaxar
Platelet aggregation inhibitors excl. heparin
Fact box
- Therapeutic class
- Platelet aggregation inhibitors excl. heparin
- Action class
- Protease-activated Receptor-1 Antagonist
- Mechanism
- Protease-activated Receptor-1 Antagonists
- Habit forming
- No
Brand names
Zontivity
Available as
2.08 MG · Oral Tablet
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.